Specific adult populations known to be at high risk for human papillomavirus (HPV)-related
disease, such as men who have sex with men, are inconsistently included in national …

The human papillomavirus (HPV) vaccine plays an important role in preventing a series of
diseases caused by HPV. Recent studies have shown that as a primary prevention measure …

The human papillomavirus (HPV) is the most prevalent sexually transmitted infection
worldwide. People living with the human immunodeficiency virus (HIV) are at high risk of …

Recent data demonstrate that human papilloma virus (HPV) plays a role in pathologies other
than ano-genital cancers, specifically head and neck malignancies, and non-cancerous …

Objectives Despite their use, differences in human papillomavirus (HPV) vaccine efficacies
remain uncertain. This study assesses efficacy differences among bivalent, quadrivalent …

Introduction: The human papillomavirus (HPV) vaccine has been reported to lead to clinical
clearance of lesions when used as an off-label treatment for recalcitrant extragenital warts …

Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

We carried out a systematic review of HPV vaccine pre-and post-licensure trials to assess
the evidence of their effectiveness and safety. We find that HPV vaccine clinical trials design …

In a large health insurance database in Germany, incidence of anogenital warts among 15-
to 19-year-old females decreased from 316/100,000 person-years in 2007 to 242 in 2008 …

Objective To summarize and determine the appropriate use for the new and old
management tools for genital warts. Sources of information The following databases were …